Pfizer’s Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the CDC’s Advisory Committee Recommendation for Invasive Disease and Pneumonia

October 21, 2021 Auto Bot CDC, Pfizer, pneumonia, PREVNAR 20, regulatory 0

Shots:

  • The CDC’s ACIP has voted to recommend Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine) to protect adults against invasive disease and pneumonia caused by the 20 S. pneumoniae serotypes
  • The ACIP has recommended one dose of Prevnar 20 for adults aged ≥65 & for ≥19yrs. with risk conditions who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown. If PCV15 is used, it should be followed by a dose of PPSV23
  • On June 8, 2021, the US FDA has approved Prevnar 20 for the prevention of invasive disease and pneumonia in adults aged ≥18yrs. and Prevnar 20 is currently under EMA’s CHMP review

Click here ­to­ read full press release/ article | Ref: Pfizer | Image: The Wall Street Journal

The post Pfizer’s Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the CDC’s Advisory Committee Recommendation for Invasive Disease and Pneumonia first appeared on PharmaShots.